Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Kidney360
; 5(5): 732-742, 2024 May 01.
Article
de En
| MEDLINE
| ID: mdl-38323855
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Dialyse rénale
/
Hyperphosphatémie
Type d'étude:
Clinical_trials
Aspects:
Patient_preference
Limites:
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Kidney360
Année:
2024
Type de document:
Article